# Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/downregulation-of-mypt1-increases-tumor-resistance-in-ovarian-cancer-by/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sandra Muñoz-Galván,Blanca Felipe‐Abrio,Eva M. Verdugo‐Sivianes,Marco Pérez,Manuel P. Jiménez-García,Elisa Suárez-Martínez,Purificación Estévez-García,Amancio Carnero |
| Citations | 122 |
| DOI | 10.1186/s12943-020-1130-z |
| Fields | Biochemistry, Genetics and Molecular Biology |
| Open Access | true |
| OA Status | gold |
| OA URL | https://molecular-cancer.biomedcentral.com/counter/pdf/10.1186/s12943-020-1130-z |
| OpenAlex ID | https://openalex.org/W3000663296 |
| PMID | 31926547 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Marco Pérez](https://scholariq.org/researchers/marco-perez/)

## Paper primary topic

- [Hippo pathway signaling and YAP/TAZ](https://scholariq.org/topics/hippo-pathway-signaling-and-yap-taz/)

## Paper topics

- [Hippo pathway signaling and YAP/TAZ](https://scholariq.org/topics/hippo-pathway-signaling-and-yap-taz/)
- [RNA Research and Splicing](https://scholariq.org/topics/rna-research-and-splicing/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.